November 4, 2015 | Dutch pharmaceutical company Mylan will begin trading on the Tel Aviv Stock Exchange (TASE) today, effectively becoming one of the largest companies listed on the Israeli exchange. The decision to dual list on the TASE and the NASDAQ, where the company’s shares are currently traded, is part of Mylan’s takeover strategy in its hostile bid for rival pharmaceutical company Perrigo.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments